VALANX Biotech offers a platform technology to the life sciences industry that enables production of protein-conjugate drugs at higher speeds and lower cost compared to the competition. These drugs cover a range of indications from cancer to vaccinations as well as diabetes. We are now establishing a product portfolio which we will further develop in partnership with pharmaceutical companies.